Lorbrexen 100 mg (Lorlatinib), generic Lorbrena is a prescription medicine used to treat metastatic non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. It is used in patients who have already received alectinib, ceritinib, or both crizotinib and at least 1 other medicine to treat NSCLC that is caused by the ALK gene. Lorbrexen is manufactured by Everest Pharma Ltd. in Bangladesh.
